Amaury Leruste

1.0k total citations
12 papers, 84 citations indexed

About

Amaury Leruste is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Amaury Leruste has authored 12 papers receiving a total of 84 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pathology and Forensic Medicine, 5 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Amaury Leruste's work include Cancer Mechanisms and Therapy (4 papers), Chromatin Remodeling and Cancer (4 papers) and interferon and immune responses (3 papers). Amaury Leruste is often cited by papers focused on Cancer Mechanisms and Therapy (4 papers), Chromatin Remodeling and Cancer (4 papers) and interferon and immune responses (3 papers). Amaury Leruste collaborates with scholars based in France, United States and Italy. Amaury Leruste's co-authors include Franck Bourdeaut, Adrienne H. Long, Daniel A. Morgenstern, Kara L. Davis, Céline Chauvin, Célio Pouponnot, Eliane Piaggio, Joshua J. Waterfall, Julien Masliah‐Planchon and Wilfrid Richer and has published in prestigious journals such as Cancer, Cancer Research and Cell Reports.

In The Last Decade

Amaury Leruste

11 papers receiving 82 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amaury Leruste France 6 44 37 32 18 13 12 84
Elen Oliveira Brazil 4 24 0.5× 35 0.9× 14 0.4× 22 1.2× 4 0.3× 5 100
Reut Riff Israel 6 25 0.6× 19 0.5× 8 0.3× 7 0.4× 19 1.5× 8 102
Fabio Gelsomino Italy 7 17 0.4× 67 1.8× 14 0.4× 25 1.4× 10 0.8× 19 99
Marina Sahade Brazil 5 18 0.4× 56 1.5× 7 0.2× 23 1.3× 23 1.8× 7 89
Sara Pezzatti Italy 4 12 0.3× 41 1.1× 28 0.9× 10 0.6× 3 0.2× 10 64
Emily C. Ayers United States 5 11 0.3× 35 0.9× 33 1.0× 9 0.5× 4 0.3× 19 69
Brent Coffey United States 5 18 0.4× 25 0.7× 13 0.4× 25 1.4× 15 1.2× 11 70
Gavin Preston United Kingdom 5 11 0.3× 17 0.5× 36 1.1× 26 1.4× 8 0.6× 10 72
Rieneke T. Lugtenberg Netherlands 4 97 2.2× 26 0.7× 36 1.1× 4 0.2× 36 2.8× 8 121
Patrick Devine United States 6 58 1.3× 9 0.2× 4 0.1× 11 0.6× 17 1.3× 17 116

Countries citing papers authored by Amaury Leruste

Since Specialization
Citations

This map shows the geographic impact of Amaury Leruste's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amaury Leruste with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amaury Leruste more than expected).

Fields of papers citing papers by Amaury Leruste

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amaury Leruste. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amaury Leruste. The network helps show where Amaury Leruste may publish in the future.

Co-authorship network of co-authors of Amaury Leruste

This figure shows the co-authorship network connecting the top 25 collaborators of Amaury Leruste. A scholar is included among the top collaborators of Amaury Leruste based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amaury Leruste. Amaury Leruste is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Aladjidi, Nathalie, Audrey Contet, Jean‐Hugues Dalle, et al.. (2024). Outcome of childhood ALK‐positive anaplastic large cell lymphoma relapses: Real‐life experience of the French Society of Pediatric Oncology (SFCE) cohort of 75 French children. Pediatric Blood & Cancer. 72(1). e31397–e31397. 1 indexed citations
2.
Yamada‐Hunter, Sean A., Johanna Theruvath, Molly Radosevich, et al.. (2023). Abstract 5741: Harnessing macrophages, while protecting T cells, enhances anti-tumor efficacy. Cancer Research. 83(7_Supplement). 5741–5741. 1 indexed citations
3.
Gatz, Susanne A., Samuel Abbou, Amaury Leruste, et al.. (2023). Abstract CT019: Phase I/II study of the PARP inhibitor olaparib and ATR inhibitor ceralasertib in children with advanced malignancies: Arm N of the AcSé-ESMART trial. Cancer Research. 83(8_Supplement). CT019–CT019. 3 indexed citations
4.
Dourthe, Marie-Émilie, Anne Aupérin, Jacques Bosq, et al.. (2022). Rituximab in addition to LMB-based chemotherapy regimen in children and adolescents with primary mediastinal large B-cell lymphoma: results of the French LMB2001 prospective study. Haematologica. 107(9). 2173–2182. 12 indexed citations
5.
Long, Adrienne H., Daniel A. Morgenstern, Amaury Leruste, Franck Bourdeaut, & Kara L. Davis. (2022). Checkpoint Immunotherapy in Pediatrics: Here, Gone, and Back Again. American Society of Clinical Oncology Educational Book. 42(42). 781–794. 18 indexed citations
6.
Leruste, Amaury, Kévin Beccaria, & François Doz. (2021). CAR-T cells for pediatric brain tumors: Present and future. Bulletin du Cancer. 108(10). S109–S116. 2 indexed citations
7.
Leruste, Amaury, Céline Chauvin, Célio Pouponnot, et al.. (2020). Immune responses in genomically simple SWI/SNF–deficient cancers. Cancer. 127(2). 172–180. 10 indexed citations
8.
Leruste, Amaury, Zhi‐Yan Han, Arnault Tauziède‐Espariat, et al.. (2018). Abstract PR03: Analysis of immune infiltrate identifies checkpoint blockade and TLR3 activation as efficient synergistic combination of immunotherapy in rhabdoid tumors. Cancer Research. 78(19_Supplement). PR03–PR03. 2 indexed citations
9.
Chauvin, Céline, Amaury Leruste, Arnault Tauziède‐Espariat, et al.. (2017). High-Throughput Drug Screening Identifies Pazopanib and Clofilium Tosylate as Promising Treatments for Malignant Rhabdoid Tumors. Cell Reports. 21(7). 1737–1745. 23 indexed citations
10.
Richer, Wilfrid, Julien Masliah‐Planchon, Nathalie Clément, et al.. (2017). Embryonic signature distinguishes pediatric and adult rhabdoid tumors from other SMARCB1-deficient cancers. Oncotarget. 8(21). 34245–34257. 7 indexed citations
11.
Leruste, Amaury, Jérôme Rambaud, Capucine Pïcard, et al.. (2016). Successful pediatric ECMO in a rare case of septic shock due to a community-acquired Legionella infection. Médecine et Maladies Infectieuses. 47(1). 68–70. 5 indexed citations
12.
Suremain, N. de, et al.. (2013). Parotidite aiguë néonatale suppurative : revue de la littérature à propos d’une observation. Archives de Pédiatrie. 21(2). 223–225.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elen Oliveira Breakdown of academic impact, for papers by Reut Riff Breakdown of academic impact, for papers by Fabio Gelsomino Breakdown of academic impact, for papers by Marina Sahade Breakdown of academic impact, for papers by Sara Pezzatti Breakdown of academic impact, for papers by Emily C. Ayers Breakdown of academic impact, for papers by Brent Coffey Breakdown of academic impact, for papers by Gavin Preston Breakdown of academic impact, for papers by Rieneke T. Lugtenberg Breakdown of academic impact, for papers by Patrick Devine
Rankless by CCL
2026